[go: up one dir, main page]

BRPI0803568B8 - composição mucoaderente - Google Patents

composição mucoaderente

Info

Publication number
BRPI0803568B8
BRPI0803568B8 BRPI0803568A BRPI0803568A BRPI0803568B8 BR PI0803568 B8 BRPI0803568 B8 BR PI0803568B8 BR PI0803568 A BRPI0803568 A BR PI0803568A BR PI0803568 A BRPI0803568 A BR PI0803568A BR PI0803568 B8 BRPI0803568 B8 BR PI0803568B8
Authority
BR
Brazil
Prior art keywords
mucoadherent
compositions
vaginal
mucoadhesive composition
prophylaxis
Prior art date
Application number
BRPI0803568A
Other languages
English (en)
Inventor
Fernanda Santana Castanho Haline
Calefe Lupércio
Original Assignee
Biolab San Us Farm Ltda
Biolab Sanus Farmaceutica Ltda
Eurofarma Laboratorios S A
Eurofarma Laboratorios LTDA
Incrementha P D & I Pesquisa Desenvolvimento E Inovacao De Farm E Medicamentos Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biolab San Us Farm Ltda, Biolab Sanus Farmaceutica Ltda, Eurofarma Laboratorios S A, Eurofarma Laboratorios LTDA, Incrementha P D & I Pesquisa Desenvolvimento E Inovacao De Farm E Medicamentos Ltda filed Critical Biolab San Us Farm Ltda
Priority to BRPI0803568A priority Critical patent/BRPI0803568B8/pt
Priority to ARP090103119A priority patent/AR073034A1/es
Priority to EP09806251.6A priority patent/EP2328550A4/en
Priority to CA2733724A priority patent/CA2733724A1/en
Priority to RU2011109393/15A priority patent/RU2011109393A/ru
Priority to MX2011001739A priority patent/MX2011001739A/es
Priority to JP2011522354A priority patent/JP2011530541A/ja
Priority to AU2009281647A priority patent/AU2009281647A1/en
Priority to CN2009801388153A priority patent/CN102170860A/zh
Priority to US13/059,032 priority patent/US20110218166A1/en
Priority to KR1020117005724A priority patent/KR20110050511A/ko
Priority to PCT/BR2009/000255 priority patent/WO2010017614A1/en
Publication of BRPI0803568A2 publication Critical patent/BRPI0803568A2/pt
Priority to IL211204A priority patent/IL211204A0/en
Priority to CO11022141A priority patent/CO6341543A2/es
Publication of BRPI0803568B1 publication Critical patent/BRPI0803568B1/pt
Publication of BRPI0803568B8 publication Critical patent/BRPI0803568B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

composições mucoaderentes e seus usos a presente invenção visa o provimento de composições mucoaderentes com aperfeiçoadas propriedades de bioadesividade, consistência, estabilidade e de regulação do ph vaginal, podendo, também ser portadora de um princípio ativo para o tratamento ou profilaxia de distúrbios ou doenças causados em mucosas, particularmente no trato vaginal, bem como seus usos.
BRPI0803568A 2008-08-14 2008-08-14 composição mucoaderente BRPI0803568B8 (pt)

Priority Applications (14)

Application Number Priority Date Filing Date Title
BRPI0803568A BRPI0803568B8 (pt) 2008-08-14 2008-08-14 composição mucoaderente
ARP090103119A AR073034A1 (es) 2008-08-14 2009-08-12 Composiciones mucoadherentes y sus usos
AU2009281647A AU2009281647A1 (en) 2008-08-14 2009-08-14 Mucoadherents compositions and their use
US13/059,032 US20110218166A1 (en) 2008-08-14 2009-08-14 Mucoadherents compositions and their use
RU2011109393/15A RU2011109393A (ru) 2008-08-14 2009-08-14 Мукоадгезивная композиция
MX2011001739A MX2011001739A (es) 2008-08-14 2009-08-14 Composiciones mucoadherentes y sus usos.
JP2011522354A JP2011530541A (ja) 2008-08-14 2009-08-14 粘膜付着性組成物およびそれらの使用
EP09806251.6A EP2328550A4 (en) 2008-08-14 2009-08-14 MUCOADHERENT COMPOSITIONS AND THEIR USE
CN2009801388153A CN102170860A (zh) 2008-08-14 2009-08-14 粘膜粘附组合物和其用途
CA2733724A CA2733724A1 (en) 2008-08-14 2009-08-14 Mucoadherents compositions and their use
KR1020117005724A KR20110050511A (ko) 2008-08-14 2009-08-14 점막접착성 조성물 및 그 용도
PCT/BR2009/000255 WO2010017614A1 (en) 2008-08-14 2009-08-14 Mucoadherents compositions and their use
IL211204A IL211204A0 (en) 2008-08-14 2011-02-13 Mucoadherents compositions and their use
CO11022141A CO6341543A2 (es) 2008-08-14 2011-02-23 Composiciones mucoadherentes y sus usos

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0803568A BRPI0803568B8 (pt) 2008-08-14 2008-08-14 composição mucoaderente

Publications (3)

Publication Number Publication Date
BRPI0803568A2 BRPI0803568A2 (pt) 2010-06-15
BRPI0803568B1 BRPI0803568B1 (pt) 2020-10-13
BRPI0803568B8 true BRPI0803568B8 (pt) 2021-05-25

Family

ID=41668595

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0803568A BRPI0803568B8 (pt) 2008-08-14 2008-08-14 composição mucoaderente

Country Status (14)

Country Link
US (1) US20110218166A1 (pt)
EP (1) EP2328550A4 (pt)
JP (1) JP2011530541A (pt)
KR (1) KR20110050511A (pt)
CN (1) CN102170860A (pt)
AR (1) AR073034A1 (pt)
AU (1) AU2009281647A1 (pt)
BR (1) BRPI0803568B8 (pt)
CA (1) CA2733724A1 (pt)
CO (1) CO6341543A2 (pt)
IL (1) IL211204A0 (pt)
MX (1) MX2011001739A (pt)
RU (1) RU2011109393A (pt)
WO (1) WO2010017614A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100158821A1 (en) * 2008-12-22 2010-06-24 Eastman Chemical Company Antimicrobial agents, compositions and products containing the same, and methods of using the compositions and products
US20110028566A1 (en) * 2009-05-15 2011-02-03 Eastman Chemical Company Compositions and products containing cycloaliphatic diol antimicrobial agents and methods of using the compositions and products
SI23309A (sl) * 2010-03-22 2011-09-30 Kemijski inštitut Kombinacija protiglivne substance in motilca znotrajcelične protonske homeostaze za uničevanje ali inhibicijo rasti in replikacije gliv
CN102293735B (zh) * 2011-08-19 2013-05-01 辽宁万嘉医药科技有限公司 一种抗真菌咪唑类药物缓释凝胶和制备方法
UA115876C2 (uk) * 2012-06-13 2018-01-10 Івофем, Інк. Композиція і спосіб підвищення ефективності бактерицидних засобів контрацепції
EP3025709B1 (en) * 2014-11-27 2020-09-30 Capsugel Belgium NV Dosage form articles for external mucosal applications
KR101882820B1 (ko) * 2015-12-30 2018-07-30 주식회사 삼양바이오팜 점막부착성 약학 조성물 및 그의 제조방법
CN106265486A (zh) * 2016-08-18 2017-01-04 滨州医学院附属医院 一种硝酸咪康唑缓释凝胶及其制备方法
WO2020076805A1 (en) * 2018-10-09 2020-04-16 Crapaud Bio, Inc. METHODS OF MAKING AND USING pH MODULATING COMPOSITIONS IN THE REPRODUCTIVE SYSTEM
CN110575431B (zh) * 2019-08-28 2021-08-03 南京天朗制药有限公司 一种阴道酸碱缓冲凝胶及制备方法
CN112933109A (zh) * 2021-02-03 2021-06-11 湖南奥朗特医疗器械有限公司 一种阴道pH调节剂及其制备方法和应用
CN113940915B (zh) * 2021-12-07 2024-04-26 南京麦澜德医疗科技股份有限公司 一种阴道内用凝胶及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69819748T2 (de) * 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
US7803392B2 (en) * 2000-12-27 2010-09-28 University Of Kentucky Research Foundation pH-Sensitive mucoadhesive film-forming gels and wax-film composites suitable for topical and mucosal delivery of molecules
US20030114394A1 (en) * 2001-10-29 2003-06-19 Levine Howard L. Vaginally administered anti-dysrhythmic agents for treating pelvic pain
ES2237298B1 (es) * 2003-07-16 2006-11-01 Italfarmaco, S.A. Formulaciones mucoadhesivas semisolidas.
US20100047371A1 (en) * 2006-08-29 2010-02-25 Mumper Russell J Compositions and methods for oral cancer chemoprevention using berry preparations and extracts

Also Published As

Publication number Publication date
CO6341543A2 (es) 2011-11-21
US20110218166A1 (en) 2011-09-08
CA2733724A1 (en) 2010-02-18
CN102170860A (zh) 2011-08-31
EP2328550A4 (en) 2013-11-20
BRPI0803568A2 (pt) 2010-06-15
MX2011001739A (es) 2011-07-05
BRPI0803568B1 (pt) 2020-10-13
RU2011109393A (ru) 2012-09-20
AU2009281647A1 (en) 2010-02-18
KR20110050511A (ko) 2011-05-13
AR073034A1 (es) 2010-10-06
IL211204A0 (en) 2011-04-28
JP2011530541A (ja) 2011-12-22
WO2010017614A1 (en) 2010-02-18
EP2328550A1 (en) 2011-06-08

Similar Documents

Publication Publication Date Title
BRPI0803568B8 (pt) composição mucoaderente
PA8780101A1 (es) Imidazopiridazina y pirrolo-pirimidinas sustituidas como inhibidores de cinasa de lipido
PA8840801A1 (es) Derivaos de dioxa-biciclo[3.2.1]octano-2,3,4-triol
NI201300035A (es) Derivados de quinazolin - 4 (3h) - ona utilizados como inhibidores de pi3 cinasa
HN2011003011A (es) Composiciones sublinguales de dexmedetomidina y metodos de uso de ellas
CO6690816A2 (es) Derivados de quinazolin-4(3h)-ona utilizados como inhibidores de pi3 cinasa
CR10211A (es) Compuestos de tiazol y métodos de uso
BRPI0912542A2 (pt) derivados de ácido 3,5-diamino-cloro-pirazina-2-carboxílico e seu uso como bloqueadores do canal de sódio epitelial para o tratamento de vias aéreas.
EP2381957A4 (en) THERAPEUTIC MODULATION OF VAGINAL ELEMENTAL BODY HUMIDIFICATION
EA201100441A1 (ru) Соединения для коррекции уровня мочевой кислоты и способы их применения
EA200802118A1 (ru) Обладающие ингибирующей активностью в отношении mnk1/mnk2 тиенопиримидины, предназначенные для применения в фармацевтических композициях
EA201000897A1 (ru) Соединения и фармацевтические композиции для снижения уровня мочевой кислоты
BRPI0802241A2 (pt) células-tronco mesenquimais e seus usos
BRPI0720270B8 (pt) compostos 4-fenil-6-(2,2,2-triflúor-1-fenil etoxi) pirimidina, composição e forma de dosagem sólida
MX350761B (es) Inhibidores de isoindolinona de fosfatidilinositol 3-cinasa.
DK2321321T3 (da) Triazolo [4,5-d]pyramidinderivater og anvendelse deraf som purinreceptorantagonister
MY150855A (en) Oral compositions containing extracts of zizyphus joazeiro and related methods
TW201129560A (en) 4-[2-[[5-methyl-1-(2-naphtalenyl)-1H-pyrazol-3-yl]oxy]ethyl]morpholine salts
WO2009109654A8 (en) 1-benzyl-3-hydr0xymethylindaz0le derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, and cx3cr1
BRPI0911678B8 (pt) maleato de orvepitant cristalino anidro, composição farmacêutica compreedendo o dito maleato e uso do mesmo para o tratamento ou profilaxia de doenças do sistema nervoso central
GT201300125A (es) 1h-pirazol-5-olato sódico sustituido
DK1988909T3 (da) Anvendelse af polyethylenglycol til inflammationsbeslægtede topiske lidelser eller sygdomme og sårheling
MX2013002121A (es) Quinolina-3-carboxamidas sustituidas como moduladores de kcnq2/3.
MX2010010345A (es) Composiciones oftalmicas topicas mejoradas.
BR112013005224A2 (pt) "agonistas de adenosina a1 para o tratamento de glaucoma e hipertensão ocular".

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4A ANUIDADE.

B08H Application fees: decision cancelled [chapter 8.8 patent gazette]

Free format text: REFERENTE A DESPACHO 8.6 NA RPI 2163 DE 19/06/2012.

B25A Requested transfer of rights approved

Owner name: EUROFARMA LABORATORIOS LTDA. (BR/SP) , BIOLAB SAN

B25D Requested change of name of applicant approved

Owner name: BIOLAB SAN US FARMACEUTICA LTDA. (BR/SP) , EUROFAR

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B25D Requested change of name of applicant approved

Owner name: EUROFARMA LABORATORIOS S.A. (BR/SP) ; BIOLAB SANUS FARMACEUTICA LTDA (BR/SP)

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 13/10/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 14/08/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF